A Novel Method for Determination of Thromboembolic Stroke Origin
Starting soon · Early Phase 1
Conditions studied: Thromboembolic Stroke
In brief
Rupture of vulnerable carotid, vertebral, and intracranial arterial plaques results in thromboembolic stroke. Identification of these culprit lesions is an important component of post-stroke care. This study seeks to test the feasibility of NaF PET-CT to detect these plaques and alter patient care. Prior studies have shown a high degree of correlation between NaF PET+ lesions and high-risk plaque features on high resolution MRI, including mirocalcification, necrosis, and ulceration.
Key facts
- Study ID
- NCT06961604
- Run by
- Atlantic Health System
- People needed
- 20
- Starts
- 2025-06-01
- Expected to finish
- 2026-05-31
- Last updated by the study team
- 2025-05-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Overlook Medical Center — Summit, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.